These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
824 related articles for article (PubMed ID: 29843747)
21. Nadir CA-125 serum levels during neoadjuvant chemotherapy and no residual tumor at interval debulking surgery predict prognosis in advanced stage ovarian cancer. Nakamura K; Kitahara Y; Nishimura T; Yamashita S; Kigure K; Ito I; Kanuma T World J Surg Oncol; 2020 Aug; 18(1):200. PubMed ID: 32791996 [TBL] [Abstract][Full Text] [Related]
22. CT prediction of surgical outcome in patients with advanced epithelial ovarian carcinoma undergoing neoadjuvant chemotherapy. Bregar A; Mojtahed A; Kilcoyne A; Kurra V; Melamed A; Growdon W; Alejandro Rauh-Hain J; Del Carmen M; Lee SI Gynecol Oncol; 2019 Mar; 152(3):568-573. PubMed ID: 30642626 [TBL] [Abstract][Full Text] [Related]
23. Potential risk factors associated with prognosis of neoadjuvant chemotherapy followed by interval debulking surgery in stage IIIc-IV high-grade serous ovarian carcinoma patients. Zhang J; Liu N; Zhang A; Bao X J Obstet Gynaecol Res; 2018 Sep; 44(9):1808-1816. PubMed ID: 30019801 [TBL] [Abstract][Full Text] [Related]
24. A preoperative low cancer antigen 125 level (≤25.8 mg/dl) is a useful criterion to determine the optimal timing of interval debulking surgery following neoadjuvant chemotherapy in epithelial ovarian cancer. Morimoto A; Nagao S; Kogiku A; Yamamoto K; Miwa M; Wakahashi S; Ichida K; Sudo T; Yamaguchi S; Fujiwara K Jpn J Clin Oncol; 2016 Jun; 46(6):517-21. PubMed ID: 26977055 [TBL] [Abstract][Full Text] [Related]
25. Clinical significance of systematic retroperitoneal lymphadenectomy during interval debulking surgery in advanced ovarian cancer patients. J Gynecol Oncol; ; . PubMed ID: 26197771 [TBL] [Abstract][Full Text] [Related]